Welcome!



Progest-Avail™

SKU: PAV30M

Product Size: 30 mL

Availability: In stock

Price: $34.00

Quick Overview

Bioidentical Progesterone
Progest-Avail™ is formulated to be used by women of reproductive age as well as by menopausal and post-menopausal women in order to ease symptoms of hormone imbalances and the normal fluctuations that occur with aging.*

Many of the health challenges women face are the result of imbalances in estrogen and progesterone. In some cases there is an absolute progesterone deficiency, while in others, very elevated estrogen (“estrogen dominance”) can induce a relative progesterone deficiency, and raising the progesterone level while also working to reduce estrogen can help correct the imbalance.* Natural bioidentical progesterone can normalize hormone imbalances with fewer side-effects than synthetic progestins.* The advantage of a topical product over an oral form is that a much lower dose is needed, as it does not need to be metabolized by the liver.



*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Progest-Avail™

More Views

Progest-Avail™ is a natural topical progesterone serum providing 20 mg of bioidentical progesterone in each 1 ml serving. This highly bioavailable progesterone serum contains just four ingredients: micronized USP progesterone, dimethyl isosorbide, caprylic/capric triglyceride (from coconut), and vitamin E. This product is free of parabens, mineral oil, and petroleum.

Progest-Avail™ consists of a super-micronized form of natural progesterone in a proprietary triglyceride carrier that facilitates better progesterone absorption than conventional creams. This serum also contains a natural sugar-based complex (dimethyl isosorbide) which increases progesterone solubility and facilitates proper penetration through skin at an efficient rate. Additionally, this compound helps preserve the potency of the progesterone, in contrast to water-based products, which are susceptible to reductions in potency of as much as 30% or more within the first 60-90 days of manufacturing due to hydrolysis of the active components.